PT3976012T - Administração intranasal de cetamina a doentes com cefaleia em salvas - Google Patents

Administração intranasal de cetamina a doentes com cefaleia em salvas

Info

Publication number
PT3976012T
PT3976012T PT207543422T PT20754342T PT3976012T PT 3976012 T PT3976012 T PT 3976012T PT 207543422 T PT207543422 T PT 207543422T PT 20754342 T PT20754342 T PT 20754342T PT 3976012 T PT3976012 T PT 3976012T
Authority
PT
Portugal
Prior art keywords
ketamine
intranasal administration
cluster headache
headache patients
patients
Prior art date
Application number
PT207543422T
Other languages
English (en)
Original Assignee
Afyx Therapeutics As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Afyx Therapeutics As filed Critical Afyx Therapeutics As
Publication of PT3976012T publication Critical patent/PT3976012T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT207543422T 2019-05-31 2020-05-29 Administração intranasal de cetamina a doentes com cefaleia em salvas PT3976012T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201962855543P 2019-05-31 2019-05-31

Publications (1)

Publication Number Publication Date
PT3976012T true PT3976012T (pt) 2024-04-09

Family

ID=72046932

Family Applications (1)

Application Number Title Priority Date Filing Date
PT207543422T PT3976012T (pt) 2019-05-31 2020-05-29 Administração intranasal de cetamina a doentes com cefaleia em salvas

Country Status (8)

Country Link
US (2) US20220218627A1 (pt)
EP (2) EP3976012B1 (pt)
DK (1) DK3976012T3 (pt)
ES (1) ES2977185T3 (pt)
FI (1) FI3976012T3 (pt)
PL (1) PL3976012T3 (pt)
PT (1) PT3976012T (pt)
WO (1) WO2020240279A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022123607A1 (en) * 2020-12-10 2022-06-16 Rubicon Research Private Limited Pharmaceutical formulations of esketamine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5543434A (en) 1994-02-25 1996-08-06 Weg; Stuart L. Nasal administration of ketamine to manage pain
AU2013305580A1 (en) * 2012-08-23 2015-04-09 Stuart L. Weg Anxiolytic composition, formulation and method of use
KR102217616B1 (ko) 2013-03-15 2021-02-19 얀센 파마슈티카 엔.브이. S-케타민 하이드로클로라이드의 약제학적 조성물
US20180177744A1 (en) * 2016-12-22 2018-06-28 Gary Jay Method of treating pain and depression using a hybrid mixture of s-ketamine and r-ketamine
US20180177743A1 (en) * 2016-12-22 2018-06-28 Gary Jay Method of treating pain using racemic mixture of s-ketamine and r-ketamine

Also Published As

Publication number Publication date
DK3976012T3 (da) 2024-04-15
EP4364812A3 (en) 2024-09-04
EP3976012A1 (en) 2022-04-06
ES2977185T3 (es) 2024-08-20
EP3976012B1 (en) 2024-03-20
US20220218627A1 (en) 2022-07-14
PL3976012T3 (pl) 2024-06-24
WO2020240279A1 (en) 2020-12-03
EP4364812A2 (en) 2024-05-08
FI3976012T3 (fi) 2024-04-05
US20230000796A1 (en) 2023-01-05

Similar Documents

Publication Publication Date Title
IL267250A (en) Enzymatic production of d-allulose
PL3558024T3 (pl) Produkcja preparatów beta-laktoglobuliny
IL269219A (en) Enzymatic creation of hexoses
IN2014CH00247A (pt)
ZA201805634B (en) Conjugate of therapeutic enzymes
EP3353292A4 (en) USE OF SERINE PROTEASE TO ENHANCE ETHANOL YIELD
EP3364956A4 (en) CELASTROL ANALOGUES
EP3331825A4 (en) SILICA FOR METHOD FOR THE PRODUCTION OF HIGH-PURITY SILICON
ZA202102826B (en) Enzymatic production of hexoses
ZA201804397B (en) Biosynthetic gene cluster of carrimycin
GB2539016B (en) Manufacture of graphene by plasma-enhanced CVD
IL291273A (en) Intranasal administration of asketamine
SG11202108304PA (en) Enzymatic production of mannose
EP3209767A4 (en) A novel purification process for isolation and commercial production of recombinant tnk-tpa (tenecteplase)
MX2015013589A (es) Proceso e intermediario para la preparacion de pregabalina.
IN2013CH04906A (pt)
PT3976012T (pt) Administração intranasal de cetamina a doentes com cefaleia em salvas
GB201709136D0 (en) New therapeutic uses of enzyme inhibitors
PT3393517T (pt) Ácido acetilsalicílico para utilização no tratamento de influenza moderada a grave
EP3297623A4 (en) METHODS OF TARGETING APE1 / REF -1 TO INHIBIT HYPOXIA SIGNALING GENES
EP4056626A4 (en) EFFECTIVE INTRANASAL ADMINISTRATION TO THE BRAIN
GB201906515D0 (en) Improvements relating to inhalers
GB201701707D0 (en) Improvements to operations of engines
WO2017098520A8 (en) PROCESS FOR THE PREPARATION OF LABETALOL CHLORHYDRATE
IL289338A (en) Therapeutic interactions of leucomethylthionine